{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:44:49Z","timestamp":1792118689866,"version":"4.4.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11939-z","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:50:14Z","timestamp":1778763014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Benzodiazepines for anxiety and depression: an updated overview of current use and major outcomes"],"prefix":"10.1007","volume":"53","author":[{"given":"Hanane","family":"EL Fatimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanane","family":"Khalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"El-Mansoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubna","family":"Khalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"1","key":"11939_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12888-025-06932-y","volume":"25","author":"Y Fan","year":"2025","unstructured":"Fan Y et al (2025) Global burden of mental disorders in 204 countries and territories, 1990\u20132021: results from the global burden of disease study 2021. BMC Psychiatry 25(1):486","journal-title":"BMC Psychiatry"},{"key":"11939_CR2","unstructured":"Who (2025) World Mental Health Today. World Mental Health Report: Transforming Mental Health For All pp. 35\u201369"},{"issue":"12","key":"11939_CR3","first-page":"3","volume":"4","author":"I Jalnapurkar","year":"2018","unstructured":"Jalnapurkar I, Allen M, Pigott T (2018) Sex differences in anxiety disorders: A review. J Psychiatry Depress Anxiety 4(12):3\u201316","journal-title":"J Psychiatry Depress Anxiety"},{"issue":"3","key":"11939_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/GME.0000000000000528","volume":"23","author":"JL Gordon","year":"2016","unstructured":"Gordon JL et al (2016) Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition. Menopause 23(3):257\u2013266","journal-title":"Menopause"},{"issue":"17","key":"11939_CR5","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.3390\/jcm14176177","volume":"14","author":"AC Courtes","year":"2025","unstructured":"Courtes AC et al (2025) Peripartum depression pharmacotherapies targeting GABA\u2013glutamate neurotransmission. J Clin Med 14(17):6177","journal-title":"J Clin Med"},{"issue":"12","key":"11939_CR6","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/brainsci11121633","volume":"11","author":"O Remes","year":"2021","unstructured":"Remes O, Mendes JF, Templeton P (2021) Biological, psychological, and social determinants of depression: a review of recent literature. Brain Sci 11(12):1633","journal-title":"Brain Sci"},{"issue":"2","key":"11939_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M (2015) Benzodiazepine use in the United States. JAMA psychiatry 72(2):136\u2013142","journal-title":"JAMA psychiatry"},{"issue":"1","key":"11939_CR8","first-page":"e6","volume":"75","author":"JD Picton","year":"2018","unstructured":"Picton JD, Marino AB, Nealy KL (2018) Benzodiazepine use and cognitive decline in the elderly. Bull Am Soc Hosp Pharmacists 75(1):e6\u2013e12","journal-title":"Bull Am Soc Hosp Pharmacists"},{"issue":"1","key":"11939_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nurpra.2020.08.004","volume":"17","author":"N McGee","year":"2021","unstructured":"McGee N, Hart AM, Burman M (2021) Reconsidering benzodiazepines and z-drug prescriptions: responsible prescribing and deprescribing. J Nurse Practitioners 17(1):76\u201383","journal-title":"J Nurse Practitioners"},{"issue":"2","key":"11939_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jcm7020017","volume":"7","author":"J Guina","year":"2018","unstructured":"Guina J, Merrill B (2018) Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives. J Clin Med 7(2):17","journal-title":"J Clin Med"},{"issue":"5","key":"11939_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.69613\/xy1yek24","volume":"2","author":"V Naveen","year":"2024","unstructured":"Naveen V et al (2024) A review on current understanding, clinical manifestations, and therapeutic approaches of anxiety disorders. J Pharma Insights Res 2(5):173\u2013181","journal-title":"J Pharma Insights Res"},{"issue":"3","key":"11939_CR12","first-page":"222","volume":"10","author":"BW Dunlop","year":"2008","unstructured":"Dunlop BW, Davis PG (2008) Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review. Prim Care Companion J Clin Psychiatry 10(3):222\u2013228","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"2","key":"11939_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1176\/appi.focus.12.2.229","volume":"12","author":"DS Baldwin","year":"2014","unstructured":"Baldwin DS et al (2014) Benzodiazepines: risks and benefits. A reconsideration. Focus 12(2):229\u2013234","journal-title":"Focus"},{"issue":"6","key":"11939_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1192\/bja.2020.18","volume":"26","author":"Y Ogawa","year":"2020","unstructured":"Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Watanabe N, Streiner D, Furukawa TA (2020) Antidepressants plus benzodiazepines for adults with major depression: a Cochrane Review. BJPsych Adv 26(6):320","journal-title":"BJPsych Adv"},{"key":"11939_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/JCP.v66n1109","volume":"66","author":"MH Pollack","year":"2005","unstructured":"Pollack MH (2005) Comorbid anxiety and depression. J Clin Psychiatry 66:22\u201329","journal-title":"J Clin Psychiatry"},{"key":"11939_CR16","doi-asserted-by":"publisher","first-page":"107402","DOI":"10.1016\/j.pharmthera.2019.107402","volume":"204","author":"SB Sartori","year":"2019","unstructured":"Sartori SB, Singewald N (2019) Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol Ther 204:107402","journal-title":"Pharmacol Ther"},{"key":"11939_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15563650.2026.2630024","volume":"10","author":"N Reiter","year":"2026","unstructured":"Reiter N, Dalhoff K, Petersen TS, Andersen CU, Wamberg CA, Clausen NE, Itenov TS, Meyhoff CS (2026) A prospective pharmacokinetic study of chlordiazepoxide in patients admitted to an intensive care unit or a high dependency unit after treatment of alcohol withdrawal symptoms. Clin Toxicol 1\u20131","journal-title":"Clin Toxicol"},{"key":"11939_CR18","unstructured":"Basit H, Kahwaji CI (2023) Clonazepam, in StatPearls [Internet]. StatPearls Publishing"},{"issue":"4","key":"11939_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN et al (2021) Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int 13(4):594\u2013607","journal-title":"Neurol Int"},{"issue":"1","key":"11939_CR20","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1038\/s41467-022-32212-4","volume":"13","author":"S Zhu","year":"2022","unstructured":"Zhu S et al (2022) Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities. Nat Commun 13(1):4582","journal-title":"Nat Commun"},{"issue":"3","key":"11939_CR21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1523\/JNEUROSCI.5012-10.2011","volume":"31","author":"J Ramerstorfer","year":"2011","unstructured":"Ramerstorfer J et al (2011) The GABAA receptor \u03b1\u2009+\u2009\u03b2 \u2013\u2009interface: a novel target for subtype selective drugs. J Neurosci 31(3):870\u2013877","journal-title":"J Neurosci"},{"issue":"7712","key":"11939_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","volume":"559","author":"S Zhu","year":"2018","unstructured":"Zhu S et al (2018) Structure of a human synaptic GABAA receptor. Nature 559(7712):67\u201372","journal-title":"Nature"},{"issue":"21","key":"11939_CR23","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1523\/JNEUROSCI.0693-10.2010","volume":"30","author":"SA Heldt","year":"2010","unstructured":"Heldt SA, Ressler KJ (2010) Amygdala-specific reduction of \u03b11-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in Mice. J Neurosci 30(21):7139\u20137151","journal-title":"J Neurosci"},{"issue":"17\u201318","key":"11939_CR24","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.drudis.2009.06.009","volume":"14","author":"C D\u2019Hulst","year":"2009","unstructured":"D\u2019Hulst C, Atack JR, Kooy RF (2009) The complexity of the GABAA receptor shapes unique pharmacological profiles. Drug Discovery Today 14(17\u201318):866\u2013875","journal-title":"Drug Discovery Today"},{"issue":"46","key":"11939_CR25","doi-asserted-by":"publisher","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","volume":"25","author":"R Dias","year":"2005","unstructured":"Dias R et al (2005) Evidence for a significant role of \u03b13-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. J Neurosci 25(46):10682\u201310688","journal-title":"J Neurosci"},{"issue":"2","key":"11939_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/toxics9020025","volume":"9","author":"E Sanabria","year":"2021","unstructured":"Sanabria E et al (2021) Benzodiazepines: their use either as essential medicines or as toxics substances. Toxics 9(2):25","journal-title":"Toxics"},{"key":"11939_CR27","unstructured":"Bounds CG, Patel P (2024) Benzodiazepines, in StatPearls [Internet]. StatPearls Publishing"},{"issue":"11","key":"11939_CR28","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.6026\/9732063002001588","volume":"20","author":"KAB Ganesh","year":"2024","unstructured":"Ganesh KAB et al (2024) Unraveling the amygdala: A review of its anatomy and functions. Bioinformation 20(11):1588\u20131592","journal-title":"Bioinformation"},{"issue":"2","key":"11939_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1037\/0735-7044.109.2.295","volume":"109","author":"J Harris","year":"1995","unstructured":"Harris J, Westbrook R (1995) Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats. Behav Neurosci 109(2):295","journal-title":"Behav Neurosci"},{"issue":"3","key":"11939_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/archpsyc.62.3.282","volume":"62","author":"MP Paulus","year":"2005","unstructured":"Paulus MP et al (2005) Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch Gen Psychiatry 62(3):282\u2013288","journal-title":"Arch Gen Psychiatry"},{"key":"11939_CR31","doi-asserted-by":"publisher","first-page":"1060949","DOI":"10.3389\/fpsyt.2022.1060949","volume":"13","author":"E Engin","year":"2023","unstructured":"Engin E (2023) GABAA receptor subtypes and benzodiazepine use, misuse, and abuse. Front Psychiatry 13:1060949","journal-title":"Front Psychiatry"},{"issue":"4","key":"11939_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0063-8","volume":"50","author":"O Babaev","year":"2018","unstructured":"Babaev O, Chatain CP, Krueger-Burg D (2018) Inhibition in the amygdala anxiety circuitry. Exp Mol Med 50(4):1\u201316","journal-title":"Exp Mol Med"},{"key":"11939_CR33","doi-asserted-by":"publisher","first-page":"102185","DOI":"10.1016\/j.jchemneu.2022.102185","volume":"126","author":"J Song","year":"2022","unstructured":"Song J et al (2022) The regional and cellular distribution of GABAA receptor subunits in the human amygdala. J Chem Neuroanat 126:102185","journal-title":"J Chem Neuroanat"},{"issue":"7","key":"11939_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.biopsych.2017.01.018","volume":"82","author":"CW Korn","year":"2017","unstructured":"Korn CW et al (2017) Amygdala lesions reduce anxiety-like behavior in a human benzodiazepine-sensitive approach\u2013avoidance conflict test. Biol Psychiatry 82(7):522\u2013531","journal-title":"Biol Psychiatry"},{"issue":"2","key":"11939_CR35","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41380-018-0310-3","volume":"26","author":"J Griessner","year":"2021","unstructured":"Griessner J et al (2021) Central amygdala circuit dynamics underlying the benzodiazepine anxiolytic effect. Mol Psychiatry 26(2):534\u2013544","journal-title":"Mol Psychiatry"},{"key":"11939_CR36","doi-asserted-by":"crossref","unstructured":"Nisbett KE, Koob GF (2025) Neuronal Colocalization of \u03bc-Opioid Receptor, \u03ba-Opioid Receptor, and Oxytocin Receptor mRNA in the Central Nucleus of the Amygdala in Male and Female Mice. Eneuro 12(9)","DOI":"10.1523\/ENEURO.0059-25.2025"},{"issue":"5","key":"11939_CR37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/brainsci13050815","volume":"13","author":"O Hosseinzadeh Sahafi","year":"2023","unstructured":"Hosseinzadeh Sahafi O et al (2023) Shared mechanisms of GABAergic and opioidergic transmission regulate corticolimbic reward systems and cognitive aspects of motivational behaviors. Brain Sci 13(5):815","journal-title":"Brain Sci"},{"issue":"2","key":"11939_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00429-016-1261-6","volume":"222","author":"BA Reyes","year":"2017","unstructured":"Reyes BA et al (2017) Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety. Brain Struct Function 222(2):1007\u20131026","journal-title":"Brain Struct Function"},{"key":"11939_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/B978-0-12-815134-1.00008-8","volume":"26","author":"MA Wilson","year":"2020","unstructured":"Wilson MA, McDonald AJ (2020) The amygdalar opioid system. Handb Behav Neurosci 26:161\u2013212","journal-title":"Handb Behav Neurosci"},{"issue":"3","key":"11939_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.pbb.2006.09.025","volume":"85","author":"SD Primeaux","year":"2006","unstructured":"Primeaux SD et al (2006) The role of delta opioid receptors in the anxiolytic actions of benzodiazepines. Pharmacol Biochem Behav 85(3):545\u2013554","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"11939_CR41","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1213\/00000539-200108000-00024","volume":"93","author":"RF Cox","year":"2001","unstructured":"Cox RF, Collins MA (2001) The effects of benzodiazepines on human opioid receptor binding and function. Anesth Analgesia 93(2):354\u2013358","journal-title":"Anesth Analgesia"},{"key":"11939_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fncel.2012.00004","volume":"6","author":"I Mody","year":"2012","unstructured":"Mody I, Maguire J (2012) The reciprocal regulation of stress hormones and GABAA receptors. Front Cell Neurosci 6:4","journal-title":"Front Cell Neurosci"},{"key":"11939_CR43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3389\/fpsyt.2020.00443","volume":"11","author":"GE Tafet","year":"2020","unstructured":"Tafet GE, Nemeroff CB (2020) Pharmacological treatment of anxiety disorders: the role of the HPA axis. Front Psychiatry 11:443","journal-title":"Front Psychiatry"},{"issue":"3","key":"11939_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11102-012-0433-5","volume":"16","author":"R Giordano","year":"2013","unstructured":"Giordano R et al (2013) Acute administration of alprazolam, a benzodiazepine activating GABA receptors, inhibits cortisol secretion in patients with subclinical but not overt Cushing\u2019s syndrome. Pituitary 16(3):363\u2013369","journal-title":"Pituitary"},{"issue":"2","key":"11939_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/cimb48020210","volume":"48","author":"C-A Martins","year":"2026","unstructured":"Martins C-A et al (2026) Modulation of corticotropin-releasing hormone receptor expression during in vitro keratinocyte differentiation. Curr Issues Mol Biol 48(2):210","journal-title":"Curr Issues Mol Biol"},{"key":"11939_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pscychresns.2018.08.015","volume":"281","author":"S Huhtaniska","year":"2018","unstructured":"Huhtaniska S et al (2018) Antipsychotic and benzodiazepine use and brain morphology in schizophrenia and affective psychoses - Systematic reviews and birth cohort study. Psychiatry Res Neuroimaging 281:43\u201352","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"1","key":"11939_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12916-024-03437-5","volume":"22","author":"Iv Hofe","year":"2024","unstructured":"Hofe Iv et al (2024) Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study. BMC Med 22(1):266","journal-title":"BMC Med"},{"key":"11939_CR48","doi-asserted-by":"publisher","first-page":"777404","DOI":"10.3389\/fnagi.2021.777404","volume":"13","author":"T Furukawa","year":"2021","unstructured":"Furukawa T et al (2021) Impaired cognitive function and hippocampal changes following chronic diazepam treatment in middle-aged mice. Front Aging Neurosci 13:777404","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"11939_CR49","doi-asserted-by":"publisher","first-page":"e84806","DOI":"10.1371\/journal.pone.0084806","volume":"8","author":"SC Licata","year":"2013","unstructured":"Licata SC et al (2013) Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment. PLoS ONE 8(12):e84806","journal-title":"PLoS ONE"},{"issue":"4","key":"11939_CR50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0028-3908(02)00152-1","volume":"43","author":"B Van Sickle","year":"2002","unstructured":"Van Sickle B et al (2002) Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression. Neuropharmacology 43(4):595\u2013606","journal-title":"Neuropharmacology"},{"issue":"3","key":"11939_CR51","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/jpet.108.144444","volume":"327","author":"K Xiang","year":"2008","unstructured":"Xiang K et al (2008) Chronic benzodiazepine administration potentiates high voltage-activated calcium currents in hippocampal CA1 neurons. J Pharmacol Exp Ther 327(3):872\u2013883","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"11939_CR52","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1038\/sj.npp.1301006","volume":"31","author":"T Welt","year":"2006","unstructured":"Welt T et al (2006) Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress. Neuropsychopharmacology 31(12):2573\u20132579","journal-title":"Neuropsychopharmacology"},{"issue":"16","key":"11939_CR53","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1089\/neu.2018.6162","volume":"36","author":"LE Villasana","year":"2019","unstructured":"Villasana LE et al (2019) Diazepam inhibits post-traumatic neurogenesis and blocks aberrant dendritic development. J Neurotrauma 36(16):2454\u20132467","journal-title":"J Neurotrauma"},{"issue":"3","key":"11939_CR54","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2147\/NDT.S2118","volume":"4","author":"L Rocha","year":"2008","unstructured":"Rocha L (2008) Subchronic treatment with antiepileptic drugs modifies pentylenetetrazol-induced seizures in mice: Its correlation with benzodiazepine receptor binding. Neuropsychiatr Dis Treat 4(3):619\u2013625","journal-title":"Neuropsychiatr Dis Treat"},{"key":"11939_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2018.10.027","volume":"75","author":"RA Whittington","year":"2019","unstructured":"Whittington RA et al (2019) Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain. Neurobiol Aging 75:11\u201324","journal-title":"Neurobiol Aging"},{"issue":"50","key":"11939_CR56","doi-asserted-by":"publisher","first-page":"16788","DOI":"10.1523\/JNEUROSCI.4101-10.2010","volume":"30","author":"K Tokuda","year":"2010","unstructured":"Tokuda K et al (2010) Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis. J Neurosci 30(50):16788\u201316795","journal-title":"J Neurosci"},{"issue":"3","key":"11939_CR57","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/ph16030331","volume":"16","author":"M Zaric Kontic","year":"2023","unstructured":"Zaric Kontic M et al (2023) Prolonged alprazolam treatment alters components of glutamatergic neurotransmission in the hippocampus of Male wistar rats\u2014the neuroadaptive changes following long-term benzodiazepine (Mis) use. Pharmaceuticals 16(3):331","journal-title":"Pharmaceuticals"},{"issue":"19","key":"11939_CR58","doi-asserted-by":"publisher","first-page":"10428","DOI":"10.18632\/aging.205087","volume":"15","author":"S Zhu","year":"2023","unstructured":"Zhu S et al (2023) Mitochondrial dysfunction following repeated administration of alprazolam causes attenuation of hippocampus-dependent memory consolidation in mice. Aging 15(19):10428\u201310452","journal-title":"Aging"},{"issue":"20","key":"11939_CR59","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1016\/j.neuron.2023.06.016","volume":"111","author":"A Tzilivaki","year":"2023","unstructured":"Tzilivaki A et al (2023) Hippocampal GABAergic interneurons and memory. Neuron 111(20):3154\u20133175","journal-title":"Neuron"},{"key":"11939_CR60","doi-asserted-by":"crossref","unstructured":"Caraiscos VB et al (2004) Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by \u03b15 subunit-containing \u03b3-aminobutyric acid type A receptors. Proceedings of the National Academy of Sciences 101(10):3662-7","DOI":"10.1073\/pnas.0307231101"},{"issue":"6","key":"11939_CR61","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/jnr.23690","volume":"94","author":"EM Prager","year":"2016","unstructured":"Prager EM et al (2016) The basolateral amygdala \u03b3-aminobutyric acidergic system in health and disease. J Neurosci Res 94(6):548\u2013567","journal-title":"J Neurosci Res"},{"key":"11939_CR62","doi-asserted-by":"publisher","first-page":"588356","DOI":"10.3389\/fnins.2020.588356","volume":"14","author":"JL Kim","year":"2020","unstructured":"Kim JL, Bulthuis NE, Cameron HA (2020) The effects of anesthesia on adult hippocampal neurogenesis. Front NeuroSci 14:588356","journal-title":"Front NeuroSci"},{"key":"11939_CR63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuropharm.2013.04.021","volume":"72","author":"Y Sun","year":"2013","unstructured":"Sun Y et al (2013) A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress. Neuropharmacology 72:20\u201328","journal-title":"Neuropharmacology"},{"issue":"2","key":"11939_CR64","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbr.2011.12.013","volume":"228","author":"Y Zhao","year":"2012","unstructured":"Zhao Y et al (2012) Beneficial effects of benzodiazepine diazepam on chronic stress-induced impairment of hippocampal structural plasticity and depression-like behavior in mice. Behav Brain Res 228(2):339\u2013350","journal-title":"Behav Brain Res"},{"issue":"9","key":"11939_CR65","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","volume":"44","author":"B Luscher","year":"2023","unstructured":"Luscher B et al (2023) GABAA receptors as targets for treating affective and cognitive symptoms of depression. Trends Pharmacol Sci 44(9):586\u2013600","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"11939_CR66","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.biopsych.2019.08.009","volume":"87","author":"C Faye","year":"2020","unstructured":"Faye C et al (2020) Rapid anxiolytic effects of RS67333, a serotonin type 4 receptor agonist, and diazepam, a benzodiazepine, are mediated by projections from the prefrontal cortex to the dorsal raphe nucleus. Biol Psychiatry 87(6):514\u2013525","journal-title":"Biol Psychiatry"},{"key":"11939_CR67","doi-asserted-by":"publisher","first-page":"100816","DOI":"10.1016\/j.cbd.2021.100816","volume":"38","author":"PA Markin","year":"2021","unstructured":"Markin PA et al (2021) Short- and medium-term exposures of diazepam induce metabolomic alterations associated with the serotonergic, dopaminergic, adrenergic and aspartic acid neurotransmitter systems in zebrafish (Danio rerio) embryos\/larvae. Comp Biochem Physiol Part D Genomics Proteom 38:100816","journal-title":"Comp Biochem Physiol Part D Genomics Proteom"},{"issue":"2","key":"11939_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00008877-199603000-00009","volume":"7","author":"EL Gibson","year":"1996","unstructured":"Gibson EL, Barnfield AM, Curzon G (1996) Dissociation of effects of chronic diazepam treatment and withdrawal on hippocampal dialysate 5-HT and mCPP-induced anxiety in rats. Behav Pharmacol 7(2):185\u2013193","journal-title":"Behav Pharmacol"},{"issue":"2","key":"11939_CR69","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/02698811241227672","volume":"38","author":"C Li","year":"2024","unstructured":"Li C et al (2024) Role of \u03b11-GABAA receptors in the serotonergic dorsal raphe nucleus in models of opioid reward, anxiety, and depression. J Psychopharmacol 38(2):188\u2013199","journal-title":"J Psychopharmacol"},{"key":"11939_CR70","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbi.2016.05.008","volume":"57","author":"K Ramirez","year":"2016","unstructured":"Ramirez K, Sheridan JF (2016) Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors. Brain Behav Immun 57:293\u2013303","journal-title":"Brain Behav Immun"},{"issue":"14","key":"11939_CR71","first-page":"45","volume":"1","author":"K Fuxe","year":"1975","unstructured":"Fuxe K et al (1975) The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons. Advances in biochemical psychopharmacology 1(14):45\u201361","journal-title":"Advances in biochemical psychopharmacology"},{"issue":"2","key":"11939_CR72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2010.04.035","volume":"477","author":"KS Hellsten","year":"2010","unstructured":"Hellsten KS et al (2010) Human locus coeruleus neurons express the GABAA receptor \u03b32 subunit gene and produce benzodiazepine binding. Neurosci Lett 477(2):77\u201381","journal-title":"Neurosci Lett"},{"issue":"10","key":"11939_CR73","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/0006-3223(95)00018-6","volume":"39","author":"P Martin","year":"1996","unstructured":"Martin P, Puech AJ (1996) Antagonism by benzodiazepines of the effects of serotonin-, but not norepinephrine-, uptake blockers in the learned helplessness paradigm in rats. Biol Psychiatry 39(10):882\u2013890","journal-title":"Biol Psychiatry"},{"key":"11939_CR74","doi-asserted-by":"publisher","first-page":"e55729","DOI":"10.7554\/eLife.55729","volume":"9","author":"PF Kramer","year":"2020","unstructured":"Kramer PF et al (2020) Axonal mechanisms mediating \u03b3-aminobutyric acid receptor type A (GABA-A) inhibition of striatal dopamine release. Elife 9:e55729","journal-title":"Elife"},{"issue":"2","key":"11939_CR75","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.pscychresns.2009.04.006","volume":"174","author":"H Vilkman","year":"2009","unstructured":"Vilkman H et al (2009) The effects of lorazepam on extrastriatal dopamine D(2\/3)-receptors-A double-blind randomized placebo-controlled PET study. Psychiatry Res 174(2):130\u2013137","journal-title":"Psychiatry Res"},{"issue":"1","key":"11939_CR76","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1124\/jpet.117.241802","volume":"364","author":"SA Schelp","year":"2018","unstructured":"Schelp SA et al (2018) Diazepam concurrently increases the frequency and decreases the amplitude of transient dopamine release events in the nucleus accumbens. J Pharmacol Exp Ther 364(1):145\u2013155","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"11939_CR77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0028-3908(90)90052-S","volume":"29","author":"T Zetterstr\u00f6m","year":"1990","unstructured":"Zetterstr\u00f6m T, Fillenz M (1990) Local administration of flurazepam has different effects on dopamine release in striatum and nucleus accumbens: a microdialysis study. Neuropharmacology 29(2):129\u2013134","journal-title":"Neuropharmacology"},{"issue":"2","key":"11939_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0163-7258(03)00029-9","volume":"98","author":"C Allison","year":"2003","unstructured":"Allison C, Pratt J (2003) Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther 98(2):171\u2013195","journal-title":"Pharmacol Ther"},{"issue":"2","key":"11939_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/npp.2008.89","volume":"34","author":"AE Heikkinen","year":"2009","unstructured":"Heikkinen AE, M\u00f6ykkynen TP, Korpi ER (2009) Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists. Neuropsychopharmacology 34(2):290\u2013298","journal-title":"Neuropsychopharmacology"},{"key":"11939_CR80","unstructured":"Consolo S, Garattini S, Ladinsky H (1975) Action of the benzodiazepines on the cholinergic system. Adv Biochem Psychopharmacol. (14):63\u201380"},{"issue":"3","key":"11939_CR81","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00508392","volume":"294","author":"G Zsilla","year":"1976","unstructured":"Zsilla G, Cheney DL, Costa E (1976) Regional changes in the rate of turnover of acetylcholine in rat brain following diazepam or muscimol. Naunyn Schmiedebergs Arch Pharmacol 294(3):251\u2013255","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"S274","key":"11939_CR82","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0447.1978.tb02383.x","volume":"58","author":"L Bertilsson","year":"1978","unstructured":"Bertilsson L (1978) Mechanism of action of benzodiazepines\u2014the GABA hypothesis. Acta psychiatrica Scandinavica 58(S274):19\u201326","journal-title":"Acta psychiatrica Scandinavica"},{"issue":"6","key":"11939_CR83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0197-0186(01)00118-8","volume":"40","author":"P Casellas","year":"2002","unstructured":"Casellas P, Galiegue S, Basile AS (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40(6):475\u2013486","journal-title":"Neurochem Int"},{"issue":"1","key":"11939_CR84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/01485017908985045","volume":"3","author":"P Cook","year":"1979","unstructured":"Cook P et al (1979) Effect of diazepam on serum testosterone and the ventral prostate gland in male rats. Arch Androl 3(1):31\u201335","journal-title":"Arch Androl"},{"issue":"5","key":"11939_CR85","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1111\/jcmm.13584","volume":"22","author":"YC Chen","year":"2018","unstructured":"Chen YC et al (2018) Midazolam inhibits chondrogenesis via peripheral benzodiazepine receptor in human mesenchymal stem cells. J Cell Mol Med 22(5):2896\u20132907","journal-title":"J Cell Mol Med"},{"issue":"1","key":"11939_CR86","doi-asserted-by":"publisher","first-page":"9335","DOI":"10.1038\/s41598-021-88599-5","volume":"11","author":"M P\u00e1dua-Reis","year":"2021","unstructured":"P\u00e1dua-Reis M et al (2021) Diazepam causes sedative rather than anxiolytic effects in C57BL\/6J mice. Sci Rep 11(1):9335","journal-title":"Sci Rep"},{"key":"11939_CR87","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3389\/fphar.2018.01523","volume":"9","author":"E Neumann","year":"2019","unstructured":"Neumann E et al (2019) Zolpidem activation of alpha 1-containing GABAA receptors selectively inhibits high frequency action potential firing of cortical neurons. Front Pharmacol 9:1523","journal-title":"Front Pharmacol"},{"issue":"1","key":"11939_CR88","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1460-9568.1999.00421.x","volume":"11","author":"ER Korpi","year":"1999","unstructured":"Korpi ER et al (1999) Cerebellar granule-cell\u2010specific GABAA receptors attenuate benzodiazepine\u2010induced ataxia: evidence from \u03b16\u2010subunit\u2010deficient mice. Eur J Neurosci 11(1):233\u2013240","journal-title":"Eur J Neurosci"},{"key":"11939_CR89","doi-asserted-by":"publisher","first-page":"172873","DOI":"10.1016\/j.pbb.2020.172873","volume":"191","author":"ME Jung","year":"2020","unstructured":"Jung ME, Metzger DB, Hall J (2020) The long-term but not short-term use of benzodiazepine impairs motoric function and upregulates amyloid \u03b2 in part through the suppression of translocator protein. Pharmacol Biochem Behav 191:172873","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"11939_CR90","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000525988","volume":"28","author":"SPG Zetsen","year":"2022","unstructured":"Zetsen SPG et al (2022) Cognitive Functioning in Long-Term Benzodiazepine Users. Eur Addict Res 28(5):377\u2013381","journal-title":"Eur Addict Res"},{"issue":"25","key":"11939_CR91","doi-asserted-by":"publisher","first-page":"10071","DOI":"10.1073\/pnas.1204606109","volume":"109","author":"A Limon","year":"2012","unstructured":"Limon A, Reyes-Ruiz JM, Miledi R (2012) Loss of functional GABA(A) receptors in the Alzheimer diseased brain. Proc Natl Acad Sci U S A 109(25):10071\u201310076","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"11939_CR92","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11055-017-0438-7","volume":"47","author":"N Dubrovina","year":"2017","unstructured":"Dubrovina N (2017) GABA receptors in the modulation of fear memory extinction. Neurosci Behav Physiol 47(5):573\u2013584","journal-title":"Neurosci Behav Physiol"},{"issue":"9","key":"11939_CR93","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1017\/S1461145709000108","volume":"12","author":"MM Savi\u0107","year":"2009","unstructured":"Savi\u0107 MM et al (2009) The differential role of \u03b11-and \u03b15-containing GABAA receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats. Int J Neuropsychopharmacol 12(9):1179\u20131193","journal-title":"Int J Neuropsychopharmacol"},{"key":"11939_CR94","unstructured":"Authier N et al (2009) D\u00e9pendance aux benzodiaz\u00e9pines: le syndrome de sevrage."},{"issue":"1","key":"11939_CR95","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","volume":"12","author":"N Ait-Daoud","year":"2018","unstructured":"Ait-Daoud N et al (2018) A review of alprazolam use, misuse, and withdrawal. J Addict Med 12(1):4\u201310","journal-title":"J Addict Med"},{"issue":"1","key":"11939_CR96","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.coph.2004.08.006","volume":"5","author":"KA Wafford","year":"2005","unstructured":"Wafford KA (2005) GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence? Curr Opin Pharmacol 5(1):47\u201352","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"11939_CR97","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pbb.2007.04.021","volume":"87","author":"LF Souza-Pinto","year":"2007","unstructured":"Souza-Pinto LF et al (2007) The blockade of AMPA-kainate and NMDA receptors in the dorsal periaqueductal gray reduces the effects of diazepam withdrawal in rats. Pharmacol Biochem Behav 87(2):250\u2013257","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"11939_CR98","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0893-133X(99)00126-8","volume":"22","author":"MJ Nijsen","year":"2000","unstructured":"Nijsen MJ et al (2000) The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat. Neuropsychopharmacology 22(4):388\u2013399","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"11939_CR99","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1192\/apt.bp.110.008631","volume":"18","author":"V Starcevic","year":"2012","unstructured":"Starcevic V (2012) Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks. Adv Psychiatr Treat 18(4):250\u2013258","journal-title":"Adv Psychiatr Treat"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11939-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:03:13Z","timestamp":1778770993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11939-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11939"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11939-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}}],"article-number":"771"}}